News Focus
News Focus
Followers 147
Posts 26147
Boards Moderated 0
Alias Born 04/08/2004

Re: None

Wednesday, 01/01/2025 12:58:25 PM

Wednesday, January 01, 2025 12:58:25 PM

Post# of 516931
The results published for the Phase 2b/3 trial using blarcamesine to treat AlzheImer’s disease is ABSOLUTELY GREAT!!!

Good luck and GOD bless,
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News